Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia

Published:1997-10 Issue:10 Volume:11 Page:1617-1620
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Kantarjian HM,O’Brien SM,Keating M,Beran M,Estey E,Giralt S,Kornblau S,Rios MB,de Vos D,Talpaz M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2400796.pdf

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 25 years of experience in the treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: results, opportunities, questions;Meditsinskiy sovet = Medical Council;2024-01-17

2. Management of chronic myeloid leukemia in 2023 – common ground and common sense;Blood Cancer Journal;2023-04-24

3. Use of low-dose decitabine with or without tyrosine kinase inhibitors in advanced phase chronic myelogenous leukemia: a systemic review and metaanalysis;2022-05-07

4. An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia;Blood;2020-06-25

5. Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia;Leukemia & Lymphoma;2017-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP